Eldred Kary
Galectin Therapeutics Inc. · Director
Eldred Kary is listed in public filings as director. This Eldred Kary insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Galectin Therapeutics Inc. (GALT). Investors use Eldred Kary's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $177k65.7k shares | BuyFeb 6, 2026 | $810300 shares | $2.70 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $182k60k shares | Grant / ExerciseJan 16, 2026 | $182.4K60k shares | $3.04 | -- | |
| $244k65.4k shares | BuyDec 23, 2025 | $2.6K700 shares | $3.73 | -- | |
| $189k64.7k shares | BuyJul 21, 2025 | $2.9K1k shares | $2.93 | -- | |
| $74k60k shares | Grant / ExerciseJan 23, 2025 | $73.8K60k shares | $1.23 | -- | |
| $52k63.7k shares | BuyDec 24, 2024 | $11.0K13.5k shares | $0.82 | -- | |
| $131k50.2k shares | BuyOct 23, 2024 | $1.3K500 shares | $2.60 | -- | |
| $119k49.7k shares | BuyJul 22, 2024 | $956400 shares | $2.39 | -- |